compound 17 [PMID: 36111834]   Click here for help

GtoPdb Ligand ID: 12185

Compound class: Synthetic organic
Comment: This is a small molecule that can be used to examine the effects of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) inhibition on the viral lifecycle [1]. Compound 17 is selective for PIKfyve, and it has been demonstrated to disrupt both entry and replication of β-coronaviruses in vitro. Its core structure was derived from the non-selective kinase inhibitor AMG28.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 1
Topological polar surface area 70.83
Molecular weight 331.18
XLogP 2.73
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CC#Cc1ccc2c(c1)c1c([nH]2)CCCc2c1nc(N)nc2)C
Isomeric SMILES Nc1ncc2CCCc3c(c2n1)c1c([nH]3)ccc(c1)C#CCN(C)C
InChI InChI=1S/C20H21N5/c1-25(2)10-4-5-13-8-9-16-15(11-13)18-17(23-16)7-3-6-14-12-22-20(21)24-19(14)18/h8-9,11-12,23H,3,6-7,10H2,1-2H3,(H2,21,22,24)
InChI Key DORZPJWJOBMQKC-UHFFFAOYSA-N
Bioactivity Comments
Compound 17 inhibits SARS-CoV-2 replication in a luciferase-based assay using human epithelial A549-ACE2 cells (IC50 19.5 nM; in the same replication assay remdesivir gave an IC50 of 86 nM), and reduces uptake of His6-SARS-CoV-2 spike protein by HEK293T-ACE2, Calu-3, and Caco-2 cells [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
phosphoinositide kinase, FYVE-type zinc finger containing Hs Inhibitor Inhibition 8.2 – 8.4 pIC50 - 1
pIC50 8.4 (IC50 4.01x10-9 M) [1]
Description: Determined in a cell-based NanoBRET assay
pIC50 8.2 (IC50 6.9x10-9 M) [1]
Description: Inhibition of hPIKFYVE in a proprietary ADP-Glo enzymatic assay
myosin light chain kinase family member 4 Hs Inhibitor Inhibition 6.6 pIC50 - 1
pIC50 6.6 (IC50 2.65x10-7 M) [1]
Description: Determined in a cell-based NanoBRET assay